September/October HTB now online

HTB SepOct 2014 coverThis new issue of HTB is now online.

Read this issue online

Download/open PDF Р(800 Kb)

This edition of HTB includes conference reports from the 54th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) and a few final – but important – ones from the IAS 2014 (20th International AIDS Conference).

Recent new drug approvals include both ARVs (including the new formulation of dolutegravir/abacavir/3TC) and DAA’s for hepatitis C (including daclatasvir) and new UK guidelines for PEP should impact on tolerability and efficacy.

Newly approved ARVs (for HIV), DAAs (for hepatitis C) and guidelines including PEP in the UK, HIV and pregnancy (BHIVA) and tenofovir and renal management (US).¬†Plus important reports from peer-reviewed publications…

Full editorial…